Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.780
-0.080 (-1.65%)
At close: Jun 12, 2026, 4:00 PM EDT
4.767
-0.014 (-0.28%)
Pre-market: Jun 15, 2026, 7:14 AM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $5.65 million as of June 15, 2026. Its market cap has increased by 197.30% in one year.
Market Cap
5.65M
Enterprise Value
-4.45M
1-Year Change
197.30%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $131.30M to $5.65M, a decrease of -95.70%. That is a compound annual growth rate of -27.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 6.00M | -31.82% |
| Dec 31, 2025 | 8.80M | 300.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -73.77% |
| Dec 30, 2022 | 12.20M | -66.94% |
| Dec 31, 2021 | 36.90M | -75.47% |
| Dec 31, 2020 | 150.40M | 367.08% |
| Dec 31, 2019 | 32.20M | 2.88% |
| Dec 31, 2018 | 31.30M | -70.02% |
| Dec 29, 2017 | 104.40M | 161.00% |
| Dec 30, 2016 | 40.00M | -69.54% |
| Jul 20, 2016 | 131.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 6.23M |
| Evogene | 6.01M |
| Cardio Diagnostics Holdings | 5.80M |
| Processa Pharmaceuticals | 5.77M |
| Enveric Biosciences | 5.63M |
| Mustang Bio | 5.60M |
| XTL Biopharmaceuticals | 5.51M |
| Liminatus Pharma | 5.48M |